First-in-man trial to investigate single, escalating doses of FV 100 in volunteers.
Phase of Trial: Phase I
Latest Information Update: 25 Oct 2008
At a glance
- Drugs Valnivudine (Primary)
- Indications Herpes zoster
- Focus Adverse reactions; Pharmacokinetics
- 25 Oct 2008 Results were presented at the 48th Interscience Conference on Antimicrobial Agents and Chemotherapy and 46th Annual Meeting of the Infectious Diseases Society of America - A Joint Meeting.
- 13 Apr 2008 Results presented at the 21st Annual International Society for Antiviral Research in April 2008.
- 08 Mar 2008 Status changed from in progress to completed according to a Inhibitex media release.